Publication:
Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan

dc.contributor.authorBolanowski, Marek (7003537848)
dc.contributor.authorAdnan, Zaina (57205149189)
dc.contributor.authorDoknic, Mirjana (6603478362)
dc.contributor.authorGuk, Mykola (57202806052)
dc.contributor.authorHána, Václav (57208751562)
dc.contributor.authorIlovayskaya, Irena (57217363017)
dc.contributor.authorKastelan, Darko (57203859133)
dc.contributor.authorKocjan, Tomaz (35588965100)
dc.contributor.authorKužma, Martin (36095961500)
dc.contributor.authorNurbekova, Akmaral (56938942100)
dc.contributor.authorPoiana, Catalina (57223932534)
dc.contributor.authorSzücs, Nikolette (6602143958)
dc.contributor.authorVandeva, Silvia (34979675100)
dc.contributor.authorGomez, Roy (55211221300)
dc.contributor.authorPaidac, Sorin (57481868000)
dc.contributor.authorSimoneau, Damien (37024931000)
dc.contributor.authorShimon, Ilan (35571386800)
dc.date.accessioned2025-06-12T12:56:46Z
dc.date.available2025-06-12T12:56:46Z
dc.date.issued2022
dc.description.abstractAcromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabolic, and osteoarticular disorders. Symptoms may emerge slowly, overlapping with other diseases and often involve many different healthcare specialists. In the last decade, efforts to provide an accurate and timely diagnosis of acromegaly have improved disease management and clinical experience. Despite this progress, marked differences in the diagnosis, treatment, and management of acromegaly exist from country-to-country. To address these inconsistencies in the region comprising Central and Eastern Europe, Israel, and Kazakhstan, a panel of acromegaly experts from 13 of these countries was convened. Acromegaly experts from each country provided available information on the approaches from their country, including regional treatment centers and multidisciplinary teams, treatment access, reimbursement and availability, and physician education, disease awareness, and patient advocacy. Across several areas of acromegaly management, divergent approaches were identified and discussed, including the provision of multidisciplinary care, approved and available treatments, and disease awareness programs. These were recognized as areas of potential improvement in the management of acromegaly, in addition to participation in national and regional acromegaly registries. Further experience exchange will facilitate the identification of specific strategies that can be adapted in each country, and widespread participation in acromegaly registries will enable their evaluation. It is anticipated that this approach will support the optimization of acromegaly patient care across this region. Copyright © 2022 Bolanowski, Adnan, Doknic, Guk, Hána, Ilovayskaya, Kastelan, Kocjan, Kužma, Nurbekova, Poiana, Szücs, Vandeva, Gomez, Paidac, Simoneau and Shimon.
dc.identifier.urihttps://doi.org/10.3389/fendo.2022.816426
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85126060075&doi=10.3389%2ffendo.2022.816426&partnerID=40&md5=b39814ac550c9ba0feb6bb6a58b7b67d
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/3632
dc.subjectacromegaly
dc.subjectendocrinology
dc.subjectIGF-I
dc.subjectmultidisciplinary care
dc.subjectreferral pathway
dc.titleAcromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
dspace.entity.typePublication

Files